Company Name, Ticker, Industry, else..

Reynolds Consumer Products Inc (REYN)

Other Ticker:

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Reynolds Consumer Products Inc

REYN's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

REYN Growth rates comparisons

Looking into Reynolds Consumer Products Inc growth rates, revenue grew by 6.56 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1590

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -15.47 %

Reynolds Consumer Products Inc 's net income grew by 1.92 % in IV. Quarter 2022 year on year, above company average,

• More on REYN's Growth

REYN's Valuation comparisons

Reynolds Consumer Products Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Reynolds Consumer Products Inc realized cash outflow of $ -0.6per share in trailing twelve-month period.

Company

22.28

PE TTM

Industry

-

PE TTM

Company's Price to Sales ratio is at 1.51.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.68.

• More on REYN's Valuation

Total Debt (Millions $)	2,091
Dividend TTM ($)	0.92 $
Dividend Yield TTM (%)	3.35 %
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	347
Tangible Book Value (Per Share $)	-4.97

REYN's Valuation comparisons

Reynolds Consumer Products Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Reynolds Consumer Products Inc realized cash outflow of $ -0.6per share in trailing twelve-month period.

Company

22.28

PE TTM

Industry

-

PE TTM

Company's Price to Sales ratio is at 1.51.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.68.

Reynolds Consumer Products Inc Price to Book Ratio is at 3.09 higher than Indusry Avg. of -0.02, and higher than S&P 500 Avg. of -0.01

• More on REYN's Valuation

• Market Capitalization (Millions $)	5,768
• Shares Outstanding (Millions)	210
• Employees	-
• Revenues (TTM) (Millions $)	3,817
• Net Income (TTM) (Millions $)	258
• Cash Flow (TTM) (Millions $)	-126
• Capital Exp. (TTM) (Millions $)	-128
• Total Debt (Millions $)	2,091
• Dividend TTM ($)	0.92 $
• Dividend Yield TTM (%)	3.35 %
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	347
• Tangible Book Value (Per Share $)	-4.97

• Market Capitalization (Millions $)	5,768
• Shares Outstanding (Millions)	210
• Employees	-
• Revenues (TTM) (Millions $)	3,817
• Net Income (TTM) (Millions $)	258
• Cash Flow (TTM) (Millions $)	-126
• Capital Exp. (TTM) (Millions $)	-128

REYN's Profitability Comparisons
Reynolds Consumer Products Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 15.63 % from 9.1 % in III. Quarter. Reynolds Consumer Products Inc net profit margin of 9.74 % is currently ranking no. 29 in Biotechnology & Pharmaceuticals industry, ranking no. 133 in Healthcare sector and number 1419 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	2.43
• Total Debt to Equity (MRQ)	1.12
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.78
• Inventory Turnover Ratio (TTM)	4.19

REYN's Profitability Comparisons

Reynolds Consumer Products Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 15.63 % from 9.1 % in III. Quarter.

Reynolds Consumer Products Inc net profit margin of 9.74 % is currently ranking no. 29 in Biotechnology & Pharmaceuticals industry, ranking no. 133 in Healthcare sector and number 1419 in S&P 500.

• More on REYN's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CALM's Profile Stock Price CALM's Financials Business Description Fundamentals Charts & Quotes CALM's News Suppliers CALM's Competitors Customers & Markets Economic Indicators CALM's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071